Gengsheng Yu

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Li Zhang, Yan Huang, Shaodong Hong et al. · The Lancet · 2016 · 515 citations

Cisplatin Versus Fluorouracil, Medicine, Metronomic Therapy +6

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study

Shaodong Hong, Yaxiong Zhang, Gengsheng Yu et al. · Journal of Clinical Oncology · 2021 · 95 citations · Full text

S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.

Rui‐Hua Xu, Zhi‐Qiang Wang, Lin Shen et al. · Journal of Clinical Oncology · 2019 · 23 citations

Surgical Oncology, Mixed-type Gastric Adenocarcinoma, Esophageal Cancer +15

Role of α1A - and α1B - Adrenoceptors in Phenylephrine-Induced Positive Inotropic Response in Isolated Rat Left Atrium

Gengsheng Yu, Chide Han · Journal of Cardiovascular Pharmacology · 1994 · 20 citations

<i>Septin 9</i> Methylation in Nasopharyngeal Swabs: A Potential Minimally Invasive Biomarker for the Early Detection of Nasopharyngeal Carcinoma

Jie-Yu Lyu, Jianyong Chen, Xiaojun Zhang et al. · Disease Markers · 2020 · 12 citations · Full text